CREATES Act of 2018
Latest action · Jun 21, 2018 Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 27, 2017
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017
This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.
Cosponsors 30
Members who signed on, in the order they did. Signatures ran from Apr 27, 2017 to Aug 22, 2018; 11 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MN | Amy Klobuchar | Original | Apr 27, 2017 |
| R-IA | Chuck Grassley | Original | Apr 27, 2017 |
| D-MO | Claire McCaskill | Original | Apr 27, 2017 |
| D-CA | Dianne Feinstein | Original | Apr 27, 2017 |
| R-AZ | John McCain | Original | Apr 27, 2017 |
| R-UT | Mike Lee | Original | Apr 27, 2017 |
| D-CT | Richard Blumenthal | Original | Apr 27, 2017 |
| D-IL | Richard J. Durbin | Original | Apr 27, 2017 |
| D-RI | Sheldon Whitehouse | Original | Apr 27, 2017 |
| R-ME | Susan M. Collins | Original | Apr 27, 2017 |
| R-AR | Tom Cotton | Original | Apr 27, 2017 |
| R-TX | Ted Cruz | Dec 5, 2017 | |
| D-NH | Margaret Wood Hassan | Dec 18, 2017 | |
| R-KY | Rand Paul | Dec 18, 2017 | |
| R-LA | John Kennedy | Feb 5, 2018 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Judiciary Committee | Referred Apr 27, 2017Markup Jun 14, 2018Reported Jun 21, 2018 |
Actions 5
Everything that happened, newest first.
- Jun 21, 2018Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
- Jun 21, 2018Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
- Jun 14, 2018Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
- Apr 27, 2017Introduced in Senate
- Apr 27, 2017Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2619)
In the Congressional Record 11
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S7221 | Chuck Grassley R-IA | Nov 29, 2018 |
| Senate | Debate and remarks S5881 | Robert Menendez D-NJ | Aug 23, 2018 |
| Senate | Debate and remarks S807 | Patrick J. Leahy D-VT | Feb 8, 2018 |
| Senate | Debate and remarks S7960 | Amy Klobuchar D-MN | Dec 12, 2017 |
| Senate | Debate and remarks S7181 | Amy Klobuchar D-MN | Nov 13, 2017 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Congressional Budget Office cost estimate
- Sep 19, 2018S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2018As reported by the Senate Committee on the Judiciary on June 21, 2018
Printed hearings 3
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 115-727 | PRESCRIPTION DRUG AFFORDABILITY AND INNOVATION: ADDRESSING CHALLENGES IN TODAY'S MARKET215 pages | Finance Committee | Jun 26, 2018 |
| S. Hrg. 115-869 | THE COST OF PRESCRIPTION DRUGS: AN EXAMINATION OF THE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE REPORT "MAKING MEDICINES AFFORDABLE: A NATIONAL IMPERATIVE"60 pages | Health, Education, Labor, and Pensions Committee | Dec 12, 2017 |
| S. Hrg. 115-312 | HEALTH CARE: ISSUES IMPACTING COST AND COVERAGE117 pages | Finance Committee | Sep 12, 2017 |
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| IF11075 | FDA and Drug Prices: Facilitating Access to Generic Drugs | Resource | Jan 17, 2019 |
| R44810 | FDA Risk Evaluation and Mitigation Strategies (REMS): Description and Effect on Generic Drug Development | Report | Mar 16, 2018 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 2212 | CREATES Act of 2017 | Identical bill | Apr 28, 2017 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
- Short Titles as Introduced
- CREATES Act of 2017
- Creating and Restoring Equal Access To Equivalent Samples Act of 2017
- Short Titles as Reported to Senate
- Creating and Restoring Equal Access to Equivalent Samples Act of 2018
- CREATES Act of 2018
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 2
Each version as it was printed, newest first.
- Jun 21, 2018Reported to Senate
- Apr 27, 2017Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.